T1	Entity 1400 1403	XPD
T2	SNP 1405 1414	Lys751Gln
T3	Entity 1416 1420	IL10
T4	SNP 1422 1431	G(-1082)A
T5	Level 1440 1456	most significant
T6	Interaction 1465 1476	interaction
E1	Interaction:T6 Entity:T4 Entity2:T2
R1	Level_marker Arg1:E1 Arg2:T5	
A1	Level E1 High
R2	SNP_coupled_gene Arg1:T2 Arg2:T1	
R3	SNP_coupled_gene Arg1:T4 Arg2:T3	
T7	Organic_inorganic_molecules_affected 1405 1414	Lys751Gln
E2	Organic_inorganic_molecules_affected:T7 Theme:T8 Agent:T2
T8	Entity 1405 1411	Lys751
T9	Entity 1422 1423;1430 1431	G A
T10	Entity 1424 1429	-1082
R4	Nucleotide_substitution Arg1:T4 Arg2:T9	
R5	SNP_location Arg1:T4 Arg2:T10	
T11	Spec 1244 1252	evidence
T12	Interaction 1265 1281;1314 1326	simple (two-way) interactions
E3	Interaction:T12 
T13	Interaction 1286 1305;1314 1326	complex (multi-way) interactions
E4	Interaction:T13 
T14	Association 1327 1337	associated
E5	Association:T14 bc:T15 snp_int:E3 snp_int2:E4
T15	Cancer 1343 1356	breast cancer
R6	Speculation_marker Arg1:E5 Arg2:T11	
R7	Member Arg1:E3 Arg2:E1	
T16	Entity 921 928	Ontario
R8	Population_assignment Arg1:E3 Arg2:T16	
R9	Population_assignment Arg1:E4 Arg2:T16	
A2	SNP_Type T2 Missense
